https://www.gosh.nhs.uk/our-research/our-research-infrastructure/nihr-great-ormond-street-hospital-brc/brc-news/?page=35

Biomedical Research Centre news

£1 million award to push forward regenerative medicine research

13 Dec 2018, 10:19 a.m.

Researchers at Great Ormond Street Hospital (GOSH) and the UCL Great Ormond Street Institute of Child Health (ICH) are to lead a new collaboration exploring how stem cells can be engineered to evade immune responses.

Professor Persis Amrolia, Consultant in Bone Marrow Transplant at Great Ormond Street Hospital (GOSH)

Autolus report initial results for cutting-edge cell therapy for cancer

7 Dec 2018, 10:11 a.m.

Clinical trials of a pioneering new cancer therapy known as AUTO3, developed by UCL spinout company Autolus Therapeutics, have shown positive initial results.

Training the next generation of paediatric researchers

27 Nov 2018, 3:33 p.m.

Paediatric researchers from across the UK came together for a special training weekend hosted by the NIHR GOSH Biomedical Research Centre (BRC) earlier this month.

GOSH to be first in UK to offer groundbreaking cancer therapy

27 Nov 2018, 8:51 a.m.

Great Ormond Street Hospital (GOSH) is to become the first hospital in the UK to offer a pioneering cancer therapy, known as CAR-T therapy, to NHS patients with B-cell acute lymphoblastic leukaemia (ALL). The first patients begin treatment at GOSH this we

$225million investment for gene therapy spinout Orchard Therapeutics

19 Nov 2018, 11:17 a.m.

Orchard Therapeutics, has launched is initial public offering (IPO) on the Nasdaq stock exchange. The company, which specialises in developing gene therapies for complex rare diseases, sold 14.3 million shares to raise $225 million of investment.